文献速递泌尿生殖腹部CT

MDCT上瘤内血管大体表现与透明细胞肾细胞癌碳酸酐酶IX评分的关联

Association of the Gross Appearance of Intratumoral Vascularity at MDCT With the Carbonic Anhydrase IX Score in Clear Cell Renal Cell Carcinoma.
PubMed 文献 · AJR Am J Roentgenol · 2018-10-09

研究纳入2001至2013年105例经病理证实的透明细胞肾细胞癌,术前行四期肾脏肿块MDCT,由两名泌尿生殖放射科医生评估瘤内血管大体表现等特征并与免疫组化CAIX评分对照。控制病灶大小和分期后,瘤内血管大体表现与CAIX评分呈显著正相关(β=38.33,p=0.010),鉴别CAIX评分200-300与0-199的OR为2.85(p=0.019)。

要点

  • MDCT上瘤内血管大体表现与透明细胞肾细胞癌CAIX评分显著正相关(β=38.33,p=0.010)。
  • 控制病灶大小和分期后,瘤内血管大体表现鉴别CAIX评分200-300与0-199的OR为2.85(p=0.019)。
  • CAIX评分目前需病理组织取样和免疫组化分析,影像生物标志物可能有助于无创预测。

核心结论

  • 在透明细胞肾细胞癌中,MDCT上瘤内血管大体表现与CAIX评分显著相关,CAIX评分是既往发现对无病生存、总生存和淋巴结受累有预后意义的分子标志物。
  • 当前CAIX评分评估需病理组织取样和免疫组化分析,可能有助于预测CAIX评分的无创影像生物标志物可能有重要临床价值。

研究设计与样本

  • 研究类型为队列研究,纳入2001至2013年105例经组织学证实的透明细胞肾细胞癌,患者术前接受四期肾脏肿块MDCT。
  • 由两名泌尿生殖放射科医生评估每个病灶的瘤内血管大体表现、钙化、强化模式、坏死、边缘、集合系统侵犯和肾静脉侵犯。
  • 采用免疫组化分析确定CAIX评分,定义为阳性染色百分比乘以染色强度,并进行logistic和线性回归分析。

关键影像表现/征象

  • 评估的MDCT特征包括瘤内血管大体表现、钙化、强化模式、坏死、边缘、集合系统侵犯和肾静脉侵犯。

诊断标准与关键数值

  • CAIX评分定义为阳性染色百分比乘以染色强度,评分范围为0-300,分析中分为0-199与200-300两组。
  • 在线性回归模型控制病灶大小和分期后,瘤内血管大体表现与CAIX评分显著正相关(β=38.33,p=0.010)。
  • 在logistic回归模型控制病灶大小和分期后,瘤内血管大体表现鉴别CAIX评分200-300与0-199的OR为2.85(p=0.019)。

临床应用与阅片要点

  • 阅片时可关注透明细胞肾细胞癌MDCT上瘤内血管的大体表现,该征象与CAIX评分独立于病灶大小和分期相关。
  • CAIX评分目前需病理组织取样和免疫组化分析,MDCT瘤内血管表现可能作为无创预测CAIX评分的影像生物标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to determine whether qualitative MDCT features are associated with the carbonic anhydrase IX (CAIX) score of clear cell renal cell carcinoma (RCC). The CAIX score has been previously found to have prognostic significance for disease-free survival, overall survival, and lymph node involvement.

MATERIALS AND METHODS: A cohort of 105 histologically proven clear cell RCCs in patients who underwent preoperative four-phase renal mass MDCT was derived from 2001 to 2013. Two genitourinary radiologists evaluated each lesion for the gross appearance of intratumoral vascularity, calcification, enhancement pattern, necrosis, margin, collecting system invasion, and renal vein invasion. Immunohistochemical analysis was used to determine the CAIX score (defined as the positive staining percentage multiplied by the staining intensity). Logistic and linear regression analyses were performed.

RESULTS: In a linear regression model controlled for lesion size and stage, the gross appearance of intratumoral vascularity had a significant positive association with CAIX score (β = 38.33, p = 0.010). In a logistic regression model controlled for lesion size and stage, the gross appearance of intratumoral vascularity had an odds ratio of 2.85 (p = 0.019) in differentiating clear cell RCCs with a CAIX score of 200-300 from clear cell RCCs with a CAIX score of 0-199.

CONCLUSION: In clear cell RCCs, the gross appearance of intratumoral vascularity at MDCT was significantly associated with CAIX score, a prognostically significant molecular marker. Current assessment of CAIX score requires pathologic tissue sampling and immunohistochemical analysis. A noninvasive imaging biomarker that may help predict CAIX score may be of great clinical value.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Young JR, Coy H, Kim HJ, et al. Association of the Gross Appearance of Intratumoral Vascularity at MDCT With the Carbonic Anhydrase IX Score in Clear Cell Renal Cell Carcinoma. AJR Am J Roentgenol. 2018. PMID: 30300009. doi:10.2214/AJR.18.19725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。